These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35397479)

  • 1. Salivary biomarkers and esophageal disorders.
    Patel V; Ma S; Yadlapati R
    Dis Esophagus; 2022 Jul; 35(7):. PubMed ID: 35397479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Pepsin Lacks Sensitivity as a Diagnostic Tool to Evaluate Extraesophageal Reflux Disease.
    Dy F; Amirault J; Mitchell PD; Rosen R
    J Pediatr; 2016 Oct; 177():53-58. PubMed ID: 27453366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pepsin in saliva as a biomarker for oropharyngeal reflux compared with 24-hour esophageal impedance/pH monitoring in pediatric patients.
    Fortunato JE; D'Agostino RB; Lively MO
    Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27604397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of salivary and nasal lavage pepsin with MII-pH testing.
    Klimara MJ; Johnston N; Samuels TL; Visotcky AM; Poetker DM; Loehrl TA; Blumin JH; Bock JM
    Laryngoscope; 2020 Apr; 130(4):961-966. PubMed ID: 31329290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China.
    Du X; Wang F; Hu Z; Wu J; Wang Z; Yan C; Zhang C; Tang J
    BMC Gastroenterol; 2017 Oct; 17(1):107. PubMed ID: 29041918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung.
    Potluri S; Friedenberg F; Parkman HP; Chang A; MacNeal R; Manus C; Bromer MQ; Malik A; Fisher RS; Nugent T; Thangada VK; Kueppers F; Miller LS
    Dig Dis Sci; 2003 Sep; 48(9):1813-7. PubMed ID: 14561007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.
    Guo Z; Wu Y; Chen J; Zhang S; Zhang C
    Med Sci Monit; 2020 Nov; 26():e927381. PubMed ID: 33220027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary peptest for laryngopharyngeal reflux and gastroesophageal reflux disease: A systemic review and meta-analysis.
    Guo Z; Jiang J; Wu H; Zhu J; Zhang S; Zhang C
    Medicine (Baltimore); 2021 Aug; 100(32):e26756. PubMed ID: 34397878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of salivary pepsin in patients with gastro-oesophageal reflux disease.
    Race C; Chowdry J; Russell JM; Corfe BM; Riley SA
    Aliment Pharmacol Ther; 2019 May; 49(9):1173-1180. PubMed ID: 30977177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease.
    Saritas Yuksel E; Hong SK; Strugala V; Slaughter JC; Goutte M; Garrett CG; Dettmar PW; Vaezi MF
    Laryngoscope; 2012 Jun; 122(6):1312-6. PubMed ID: 22447277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary pepsin for the diagnosis of gastroesophageal reflux disease: what is its role in 2020?
    Mari A; Pellicano R; Khoury T
    Minerva Gastroenterol Dietol; 2020 Sep; 66(3):181-183. PubMed ID: 32327625
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
    Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
    Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pepsin: biomarker, mediator, and therapeutic target for reflux and aspiration.
    Johnston N; Dettmar PW; Ondrey FG; Nanchal R; Lee SH; Bock JM
    Ann N Y Acad Sci; 2018 Dec; 1434(1):282-289. PubMed ID: 29774546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting laryngopharyngeal reflux in patients with upper airways symptoms: Symptoms, signs or salivary pepsin?
    Spyridoulias A; Lillie S; Vyas A; Fowler SJ
    Respir Med; 2015 Aug; 109(8):963-9. PubMed ID: 26044812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abilities of Oropharyngeal pH Tests and Salivary Pepsin Analysis to Discriminate Between Asymptomatic Volunteers and Subjects With Symptoms of Laryngeal Irritation.
    Yadlapati R; Adkins C; Jaiyeola DM; Lidder AK; Gawron AJ; Tan BK; Shabeeb N; Price CP; Agrawal N; Ellenbogen M; Smith SS; Bove M; Pandolfino JE
    Clin Gastroenterol Hepatol; 2016 Apr; 14(4):535-542.e2. PubMed ID: 26689899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary pepsin A detection related to gastro-oesophageal reflux episodes in children undergoing impedance probe monitoring.
    Haddad HA; He Z; Shaffer SE; Molle-Rios ZL
    Acta Paediatr; 2020 Nov; 109(11):2374-2379. PubMed ID: 32239539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of bile acids on the severity of laryngo-pharyngeal reflux.
    De Corso E; Baroni S; Salonna G; Marchese M; Graziadio M; Di Cintio G; Paludetti G; Costamagna G; Galli J
    Clin Otolaryngol; 2021 Jan; 46(1):189-195. PubMed ID: 32876387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchoalveolar pepsin, bile acids, oxidation, and inflammation in children with gastroesophageal reflux disease.
    Starosta V; Kitz R; Hartl D; Marcos V; Reinhardt D; Griese M
    Chest; 2007 Nov; 132(5):1557-64. PubMed ID: 17925430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway reflux.
    Johnston N; Ondrey F; Rosen R; Hurley BP; Gould J; Allen J; DelGaudio J; Altman KW
    Ann N Y Acad Sci; 2016 Oct; 1381(1):5-13. PubMed ID: 27310222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary bicarbonate as a major factor in the prevention of upper esophageal mucosal injury in gastroesophageal reflux disease.
    Skoczylas T; Yandrapu H; Poplawski C; Asadi M; Wallner G; Sarosiek J
    Dig Dis Sci; 2014 Oct; 59(10):2411-6. PubMed ID: 24610537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.